Scientific Sessions 2025  /  Transformative Advances in Genome Engineering for Precision Therapy  /  Ethical considerations of gene editing technologies
Logo

American Heart Association

  48
  0

Final ID:

Ethical considerations of gene editing technologies

  • Magnus, David  ( Stanford , California , California , United States )
  • Tabort, Holly  ( Stanford , California , California , United States )
  • Saha, Krishanu  ( University of Wisconsin , Madison , Wisconsin , United States )
    • Author Disclosures:
    david magnus: No Answer | Holly Tabort: DO NOT have relevant financial relationships | Krishanu Saha: DO have relevant financial relationships ; Advisor:Bharat Biotech:Active (exists now) ; Advisor:Notch Therapeutics:Past (completed) ; Advisor:Andson Biotech:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Transformative Advances in Genome Engineering for Precision Therapy

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Developing single course in vivo gene editing therapies for hyperlipidemia

Kathiresan Sekar, Musunuru Kiran, Ishikawa Kiyotake

Treating cardiovascular disease with Base and Prime Editing

Seidman Christine, Steinmetz Lars, Olson Eric

You have to be authorized to contact abstract author. Please, Login
Not Available